Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

NCT01020396 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
579
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Teva Pharmaceuticals USA